Results 191 to 200 of about 15,613 (254)

Crovalimab: a new era in paroxysmal nocturnal hemoglobinuria management. [PDF]

open access: yesAnn Med Surg (Lond)
Waheed A   +6 more
europepmc   +1 more source

HSD51 Evaluation of the Healthcare System Burden Associated With Intravenous Treatment for Paroxysmal Nocturnal Hemoglobinuria [PDF]

open access: bronze
BP Mulherin   +11 more
openalex   +1 more source

What are the most important quality of life domains for patients with aplastic anemia and paroxysmal nocturnal hemoglobinuria? [PDF]

open access: yesAnn Hematol
Taylor KJ   +9 more
europepmc   +1 more source

Safety, Efficacy, and Patient-Reported Outcomes From a Phase 2 Randomized Trial of Pozelimab and Cemdisiran Combination in Patients With Paroxysmal Nocturnal Hemoglobinuria. [PDF]

open access: yesEJHaem
Jang JH   +12 more
europepmc   +1 more source

Managing transient immune complex reactions in patients with paroxysmal nocturnal hemoglobinuria: clinical observations from the COMMODORE 1 and 2 studies. [PDF]

open access: yesTher Adv Hematol
Kulasekararaj AG   +9 more
europepmc   +1 more source

FDA approval of crovalimab: a milestone in paroxysmal nocturnal hemoglobinuria treatment. [PDF]

open access: yesAnn Med Surg (Lond)
Anwar D   +6 more
europepmc   +1 more source

Real-World Prevalence and Outcomes of Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with C5 Inhibitors in the US: A Retrospective Claims Database Analysis. [PDF]

open access: yesJ Health Econ Outcomes Res
Tantravahi SK   +9 more
europepmc   +1 more source

Somatic mutations in Brazilian patients with paroxysmal nocturnal hemoglobinuria: a comprehensive analysis. [PDF]

open access: yesFront Med (Lausanne)
Eiko Yamakawa P   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy